Original Research

Prostate Cancer Therapy Using Docetaxel and Formononetin Combination: Hyaluronic Acid and Epidermal Growth Factor Receptor Targeted Peptide Dual Ligands Modified Binary Nanoparticles to Facilitate the in vivo Anti-Tumor Activity

Dong Z, Wang Y, Guo J, Tian C, Pan W, Wang H, Yan J

Drug Design, Development and Therapy 2022, 16:2683-2693

Published Date: 11 August 2022